期刊文献+

国产奥沙利铂治疗晚期大肠癌临床验证研究 被引量:7

Trial of Domestic-made Oxaliplatin in Patients with Advanced Colorectal Carcinoma
下载PDF
导出
摘要 目的 评价国产奥沙利铂治疗晚期大肠癌的疗效和安全性。方法 将 78例大肠癌患者随机分为 A、B两组。 A组为奥沙利铂试验组 ,B组为顺铂对照组 ,治疗 2周后评价疗效 ,有效病例在 4周后确认疗效。结果 共入组 78例 ,可评价病例 74例中 ,A组有效率为 2 8.9% ,B组有效率为 5 .5 6 % (P<0 .0 1 )。不良反应主要为恶心、呕吐和感觉神经毒性。结论 国产奥沙利铂联合氟脲嘧啶 -甲酰四氢叶酸钙治疗晚期大肠癌疗效与同方案进口奥沙利铂疗效基本相近 ,比以顺铂为主的对照组方案疗效要高 (P<0 .0 1 ) Objective The aim of this project was to evaluate the efficacy and adverse effects of Oxaliplatin(L\|OHP) in advanced colorectal cancer(ACRC). Methods A randomized study of this drug versus combination with 5\|FU/FA in ACRC patients was conducted in 12 hospitals. Arm A with L\|0HP Arm B is a group contrasted with cisplatin, Tumor assessment dosdone every 2 cycles and responders were confirmed four weeks later.Results 78 ACRC patients entered the study, 74 cases evaluable for efficacy, the response rate for arm A and B of ACRC was 28.95%(11/38) and5.56%(2/36)( P <0.01). The main adverse effects were nauseu and vomiting ,alopecia and neuro\|sensory toxicity.Conclusion The response rate in ACRC of domestic\|made L\|OHP was encouraging and comparable with eloxatin, The response rate was better than arm B of cisplatin.
出处 《肿瘤防治研究》 CAS CSCD 2001年第3期234-236,共3页 Cancer Research on Prevention and Treatment
关键词 大肠癌 奥沙利铂 氟脲嘧啶 甲酰四氢叶酸钙 顺铂 药物疗法 治疗 Colorectal neoplasms Oxalipoatin 5\|FU Cisplatin CF
  • 相关文献

参考文献3

二级参考文献2

共引文献343

同被引文献43

  • 1李苏宜,刘琳,顾小怡,姜藻,王彩莲,董丽钧,万建平.草酸铂联合氟尿嘧啶、醛氢叶酸治疗晚期结直肠癌的临床观察[J].临床肿瘤学杂志,2006,11(8):612-614. 被引量:8
  • 2王国强,万德森,周志伟,潘志忠,陈功,卢震海,方淯靖,伍小军,李力人,丁培荣.FOLFOX6方案治疗结直肠癌肝转移患者的疗效观察[J].癌症,2007,26(4):411-414. 被引量:10
  • 3高凌峰,谭煌英,李园,朱世杰,崔慧娟,李利亚.以草酸铂为主方案用于结直肠癌术后辅助化疗的疗效分析[J].癌症进展,2007,5(3):294-297. 被引量:6
  • 4杨沛新,程若川,刁畅,张建明,魏晓平,苏艳军.Ⅲ期结直肠癌术后三种辅助化疗方案的疗效及安全性比较[J].昆明医学院学报,2007,28(02B):40-47. 被引量:8
  • 5De Gramont A, Boni C, Navarro M, et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years[C]. J Clin Oncol. 2007,25(suppl) :4007.
  • 6Kuebler JP,Wieand HS, OConnell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer: results from NSABP C-07[J]. J Clin Oncol, 2007, 25(16) :2198- 2204.
  • 7Wolmark N, Wieand S, Kuebler PJ, et al. A phase Ⅲ trial comparing FULV to FULV + oxaliplatin in stage Ⅱ or Ⅲ carcinoma of the colon: Survival results of NSABP Protocol C-07 [C]. J Clin Oncol, 2008,26(suppl) : LBA4005.
  • 8Land SR,Kopec JA,Cecchini RS, et al. Neurotoxicity from ox aliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer:NSABP C-07 [J]. J Clin Oncol, 2007, 25 (16) : 2205- 2211.
  • 9Schmoll H,Cartwright T, Tabernero J, et al. Phase Ⅲ trial of capecitabine plus oxaliplatin as adjuvant therapy for stage Ⅲ colon cancer: a planned safety analysis in 1,864 patients[J]. J Clin Oncol, 2007,5(1) : 102-109.
  • 10Twelves C, Wong A, Nowacki MP,et al. Capecitabine as ad juvam treatment for stage III colon cancer[J].N Engl J Med, 2005,352 (26) : 2696-2704.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部